$ADAP can rise in the next days

Contextual immersion trading strategy idea.

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States.

Friday morning the company presented positive data on its experimental cell therapy, which is designed to treat a range of cancers. It causes a rise in the share price. I see some preconditions the share price will continue growing.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price in the next days.

So I opened a long position from $11,85;
stop-loss — $11,18.

Information about take-profits will be later.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.

Thanks for being with me!